Eastman Chemical Sees Unusually High Options Volume (NYSE:EMN)

Eastman Chemical Company (NYSE:EMNGet Free Report) saw unusually large options trading on Wednesday. Stock investors purchased 10,251 call options on the company. This represents an increase of approximately 813% compared to the typical volume of 1,123 call options.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on EMN. UBS Group increased their target price on Eastman Chemical from $80.00 to $88.00 and gave the stock a “buy” rating in a research note on Thursday, April 9th. Citigroup boosted their price target on Eastman Chemical from $83.00 to $88.00 and gave the company a “buy” rating in a research note on Monday, May 4th. Wells Fargo & Company increased their price objective on Eastman Chemical from $70.00 to $80.00 and gave the stock an “equal weight” rating in a research report on Monday, May 4th. Morgan Stanley lifted their target price on Eastman Chemical from $73.00 to $83.00 and gave the stock an “overweight” rating in a report on Tuesday, May 5th. Finally, Mizuho set a $85.00 target price on shares of Eastman Chemical in a research report on Friday, May 1st. Seven research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $80.25.

Get Our Latest Stock Analysis on EMN

Eastman Chemical Stock Performance

Shares of EMN traded up $1.26 during mid-day trading on Wednesday, hitting $70.74. 398,516 shares of the company’s stock were exchanged, compared to its average volume of 1,484,833. The company has a quick ratio of 0.71, a current ratio of 1.47 and a debt-to-equity ratio of 0.73. Eastman Chemical has a 52 week low of $56.11 and a 52 week high of $83.47. The stock’s 50-day simple moving average is $73.22 and its 200-day simple moving average is $71.35. The firm has a market cap of $8.09 billion, a price-to-earnings ratio of 20.52, a price-to-earnings-growth ratio of 0.91 and a beta of 1.04.

Eastman Chemical (NYSE:EMNGet Free Report) last issued its quarterly earnings results on Thursday, April 30th. The basic materials company reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.07 by $0.02. The business had revenue of $2.18 billion during the quarter, compared to analysts’ expectations of $2.17 billion. Eastman Chemical had a return on equity of 8.88% and a net margin of 4.62%.The firm’s revenue for the quarter was down 4.9% compared to the same quarter last year. During the same period in the previous year, the company posted $1.91 earnings per share. Eastman Chemical has set its Q2 2026 guidance at 1.700-1.900 EPS. On average, equities research analysts expect that Eastman Chemical will post 6.36 EPS for the current year.

Eastman Chemical Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 8th. Stockholders of record on Monday, June 15th will be given a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a dividend yield of 4.8%. The ex-dividend date is Monday, June 15th. Eastman Chemical’s dividend payout ratio is presently 97.39%.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the stock. QSM Asset Management Ltd boosted its position in shares of Eastman Chemical by 27.0% during the 4th quarter. QSM Asset Management Ltd now owns 120,258 shares of the basic materials company’s stock worth $7,676,000 after acquiring an additional 25,550 shares in the last quarter. HighTower Advisors LLC raised its position in Eastman Chemical by 42.7% during the third quarter. HighTower Advisors LLC now owns 47,788 shares of the basic materials company’s stock valued at $3,013,000 after purchasing an additional 14,294 shares in the last quarter. Invenomic Capital Management LP lifted its stake in Eastman Chemical by 119.9% during the third quarter. Invenomic Capital Management LP now owns 131,690 shares of the basic materials company’s stock worth $8,303,000 after purchasing an additional 71,794 shares during the last quarter. Numerai GP LLC lifted its stake in Eastman Chemical by 601.2% during the third quarter. Numerai GP LLC now owns 37,551 shares of the basic materials company’s stock worth $2,368,000 after purchasing an additional 32,196 shares during the last quarter. Finally, Huntington National Bank boosted its holdings in shares of Eastman Chemical by 31.8% in the 3rd quarter. Huntington National Bank now owns 110,576 shares of the basic materials company’s stock valued at $6,972,000 after purchasing an additional 26,704 shares in the last quarter. Institutional investors own 83.65% of the company’s stock.

Eastman Chemical Company Profile

(Get Free Report)

Eastman Chemical Company (NYSE: EMN) is a global specialty materials company that develops, manufactures and markets a broad range of advanced materials, chemicals and fibers. Its product portfolio spans performance additives, functional products, and engineered plastics designed to enhance the durability, appearance and performance of end products across diverse industries.

The company’s main business activities include the production of specialty chemicals used in adhesives, coatings, building materials and consumer care applications, as well as high-performance plastics for packaging, automotive and electronics markets.

Read More

Receive News & Ratings for Eastman Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eastman Chemical and related companies with MarketBeat.com's FREE daily email newsletter.